Vitamin E and cardiovascular protection in diabetesBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7098.1845 (Published 28 June 1997) Cite this as: BMJ 1997;314:1845
Antioxidants may offer particular advantage in this high risk group
- Anastasios Gazis, Clinical research fellowa,
- Simon Page, Consultant physiciana,
- John Cockcroft, Senior lecturera
- a Department of Medicine and Department of Diabetes, Endocrinology and Nutrition, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH
Atheromatous vascular disease is responsible for 70% of deaths in patients with diabetes and a twofold to fourfold excess mortality in those with impaired glucose tolerance.1 Although diabetes is an independent risk factor for cardiovascular disease, some excess risk may also be related to the association of diabetes with other risk factors, including hyperlipidaemia and hypertension in the “metabolic syndrome.” However, treating these risk factors is unlikely to have a major impact on cardiovascular complications associated with diabetes.2 New approaches to reducing cardiovascular risk in diabetes need to be assessed.
Increased awareness of the role of oxidative stress in the pathogenesis of atheroma3 has opened new avenues for research. One peroxidation product, oxidised low density lipoprotein (ox-LDL), damages the vascular endothelium and is potently atherogenic. It impairs endothelium dependent relaxation, which is mediated by nitric oxide, an endogenous vasodilator with antiatherogenic properties. Impaired endothelium dependent relaxation may be a …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial